DUBLIN--(BUSINESS WIRE)--The "Coagulation Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Coagulation Testing Market to Reach $3.5 Billion by 2027
Amid the COVID-19 crisis, the global market for Coagulation Testing estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 7.7% over the period 2020-2027.
Instruments, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$679 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $571.3 Million, While China is Forecast to Grow at 11.5% CAGR
The Coagulation Testing market in the U.S. is estimated at US$571.3 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$776.6 Million by the year 2027 trailing a CAGR of 11.3% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 6.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
Select Competitors (Total 38 Featured):
- Abbott Laboratories, Inc.
- Agappe Diagnostics Ltd.
- Alere, Inc.
- F. Hoffmann-La Roche AG
- Helena Laboratories, Inc.
- HemoSonics, LLC
- Horiba, Ltd.
- Medtronic PLC
- Randox Laboratories Ltd.
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Universal Biosensors Inc.
For more information about this report visit https://www.researchandmarkets.com/r/8u94te